je.st
news
Tag: inhibitor
New GE Corrosion Inhibitor Protects Crude Oil And Gas Pipelines
2015-05-05 04:20:47| oilandgasonline News Articles
GE recently introduced a new corrosion inhibitor to help protect crude oil and gas pipelines against the corrosive nature of acid gases. GE made its announcement at the Offshore Technology Conference taking place May 4-7, 2015, in Houston.
GE launches ProSolv Wax Inhibitor to facilitate uninterrupted flow of oil
2015-05-05 01:00:00| Hydrocarbons Technology
GE has launched a new range of wax inhibitors which can help uninterrupted flow of crude oil from the reservoir to the point of sale.
Tags: flow
oil
facilitate
launches
Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of Anti-PD-1 Therapy with Multi-targeting RTK Inhibitor and Microtubule Dynamics Inhibitor in Multiple Types of Cancer
2015-03-05 00:30:00| Merck.com - Product News
Dateline City: TOKYO & KENILWORTH, N.J. Combination clinical studies of lenvatinib, eribulin and pembrolizumab to be explored TOKYO & KENILWORTH, N.J.--(BUSINESS WIRE)--Eisai Co., Ltd. and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, through a subsidiary, announced today a clinical trial collaboration to evaluate the safety, tolerability and efficacy of Mercks anti-PD-1 therapy, pembrolizumab (marketed in the U.S. under the brand name KEYTRUDA), in combination with Eisai oncology compounds lenvatinib mesylate (a multi-targeting RTK inhibitor marketed in the U.S. Language: English Contact: Eisai Public Relations Department+81-(0)3-3817-5120orEisai Investor Relations+81-(0)3-3817-5327orMerck Media RelationsPamela Eisele, 267-305-3558or Claire Mulhearn, 908-236-1118orMerck Investor RelationsJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Corrosion Inhibitor targets petroleum refiners.
2015-01-26 14:31:26| Industrial Newsroom - All News for Today
Offering effective passivation and ongoing protection with up to 80% less phosphorous than other HTCI products, TANSCIENT™ allows for safe and reliable refining of high TAN opportunity crudes. Product offers optimized thermal stability and oil solubility as well as maximum surface reactivity. With low acidity, TRANSCIENT does not require cooled slipstream for injection. Inhibitor also minimizes risk of phosphorous fouling and catalyst impairment.
Tags: targets
petroleum
inhibitor
corrosion
Merck Submits New Drug Application to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes
2014-11-24 14:00:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes, to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Language: English Contact: MerckMedia:Pam Eisele267-305-3558orKim Hamilton908-740-1863 / 908-391-0131orInvestors:Justin Holko908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
type
application
medical